Back to search
FDAFDA · Food and drugs·Recall number D-0211-2018

Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bottle, Rx Only. Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701. NDC: 50383-311-47

Published January 17, 2018 · Recall initiated: December 15, 2017

Summary

FDA records drug Class III recall D-0211-2018, published January 17, 2018 and initiated December 15, 2017. Recalling firm: Akorn Inc; Status: Terminated; Reported quantity: 4,885 bottles; Lot: Batch# 359774; Exp. 09/02/19. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn Inc
Distributor
Nationwide
Lot
Batch# 359774; Exp. 09/02/19
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gabapentin Oral Solution, 250 mg/5 mL (50 mg/mL) in a 470 mL amber-colored bottle, Rx Only. Manufactured by: Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701. NDC: 50383-311-47 recalled?

Yes. FDA published recall D-0211-2018 on January 17, 2018. Reported hazard: CGMP Deviations: Inadvertent release of a drug product with unapproved active ingredient manufacturer.

What should I do if I have this product?

Voluntary: Firm initiated · Letter